Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Plant-based Diets for Improving Lipids

National Lipid Association

K. Williams

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

American Heart & Vascular Institute

M. Kittleson

Diabetes and Heart Failure: The New Frontier

Mount Sinai Advanced Innovations in Heart Failure Symposium 2019

E. Braunwald

Targeting Inflammation to Prevent Cardiovascular Disease - Ready for…

National Lipid Association

M. Garshick

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Piedmont Heart Institute

J. Burkle

ASCVD Risk Assessment and Prevention: Where Do We Stand Now?

Cardiometabolic Health Congress (CMHC)

S. Virani

Primary Prevention of Cardiovascular Disease in Women: Blood Pressur…

Cedars Sinai

N. Bello

The Effect of Cancer Therapies on Diabetes

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

E. Gallagher

Novel Therapies in Heart Failure: What Are the Indications and Contr…

American Heart & Vascular Institute

L. Kemeyou

What Diet Is Best for Cardiovascular Health?

Cedars Sinai

K. Williams

The Dangerous Intersection of Diabetes and Heart (and Kidney) Disease

Inova Cherry Blossom Cardiovascular Symposium 2022

D. K. Mcguire